Editor’s Corner
Solving the Contract Research
Agonization Problem
I
The content of the Editor’s Corner is
the opinion of the authors and does
not represent the official position of
the American Society of Hematology
unless so stated.
N THE JUNE 2017 ISSUE of ASH Clinical News, we published
an editorial calling into question some of the purposes and
practices of contract research organizations (CROs), which
came into existence in the 1980s and are used by much of the
pharmaceutical industry to outsource research regulatory
requirements. Although CROs – considered specialists in the
day-to-day minutiae of clinical trial conduct – should be the
epitome of high-quality data